60
Newleos Therapeutics, Inc. raises $93.4M under Reg D
Company raise · Closed · BOSTON, MA · Form D filed 2025-02-24
$50M+ raiseFirst raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| David Donabedian | Executive Officer, Director |
| Robert Hadfield | Executive Officer |
| Christoph Westphal | Director |
| Ming Cheah | Director |
| Raymond Camahort | Director |
| John McCabe | Executive Officer |
Signed by David Donabedian, President and CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.